nodes	percent_of_prediction	percent_of_DWPC	metapath
Naproxen—migraine—Prednisone—systemic lupus erythematosus	0.117	0.341	CpDpCtD
Naproxen—osteoarthritis—Prednisone—systemic lupus erythematosus	0.113	0.33	CpDpCtD
Naproxen—osteoarthritis—Methylprednisolone—systemic lupus erythematosus	0.113	0.33	CpDpCtD
Naproxen—PTGS2—systemic lupus erythematosus	0.0985	0.529	CbGaD
Naproxen—ALB—systemic lupus erythematosus	0.0878	0.471	CbGaD
Naproxen—UGT2B7—Mycophenolate mofetil—systemic lupus erythematosus	0.0323	0.0994	CbGbCtD
Naproxen—UGT1A1—Mycophenolate mofetil—systemic lupus erythematosus	0.028	0.0859	CbGbCtD
Naproxen—PTGS2—Dapsone—systemic lupus erythematosus	0.0194	0.0596	CbGbCtD
Naproxen—SLCO1A2—Prednisolone—systemic lupus erythematosus	0.0174	0.0534	CbGbCtD
Naproxen—PTGS2—Triamcinolone—systemic lupus erythematosus	0.0168	0.0517	CbGbCtD
Naproxen—SLCO1A2—Hydrocortisone—systemic lupus erythematosus	0.0165	0.0506	CbGbCtD
Naproxen—SLCO1A2—Prednisone—systemic lupus erythematosus	0.0164	0.0504	CbGbCtD
Naproxen—PTGS1—Dapsone—systemic lupus erythematosus	0.0164	0.0503	CbGbCtD
Naproxen—SLCO1A2—Cyclosporine—systemic lupus erythematosus	0.0155	0.0478	CbGbCtD
Naproxen—PTGS2—Betamethasone—systemic lupus erythematosus	0.0144	0.0443	CbGbCtD
Naproxen—ALB—Mycophenolate mofetil—systemic lupus erythematosus	0.0106	0.0326	CbGbCtD
Naproxen—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0103	0.0315	CbGbCtD
Naproxen—SLCO1A2—Dexamethasone—systemic lupus erythematosus	0.0102	0.0315	CbGbCtD
Naproxen—CYP2C8—Dapsone—systemic lupus erythematosus	0.00945	0.029	CbGbCtD
Naproxen—SLC22A6—Cyclosporine—systemic lupus erythematosus	0.00943	0.029	CbGbCtD
Naproxen—CYP2C9—Leflunomide—systemic lupus erythematosus	0.00925	0.0284	CbGbCtD
Naproxen—ALB—Prednisone—systemic lupus erythematosus	0.00847	0.026	CbGbCtD
Naproxen—PTGS2—Dexamethasone—systemic lupus erythematosus	0.00839	0.0258	CbGbCtD
Naproxen—SLCO1A2—Methotrexate—systemic lupus erythematosus	0.00823	0.0253	CbGbCtD
Naproxen—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.00819	0.0252	CbGbCtD
Naproxen—CYP2C9—Dapsone—systemic lupus erythematosus	0.00659	0.0203	CbGbCtD
Naproxen—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00657	0.0202	CbGbCtD
Naproxen—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00621	0.0191	CbGbCtD
Naproxen—SLC22A6—Methotrexate—systemic lupus erythematosus	0.00499	0.0153	CbGbCtD
Naproxen—CYP2C9—cardial valve—systemic lupus erythematosus	0.0046	0.196	CbGeAlD
Naproxen—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00433	0.0133	CbGbCtD
Naproxen—ALB—Methotrexate—systemic lupus erythematosus	0.00425	0.0131	CbGbCtD
Naproxen—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00409	0.0126	CbGbCtD
Naproxen—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00285	0.00876	CbGbCtD
Naproxen—UGT1A1—urine—systemic lupus erythematosus	0.00236	0.101	CbGeAlD
Naproxen—UGT1A1—blood plasma—systemic lupus erythematosus	0.00123	0.0526	CbGeAlD
Naproxen—CYP1A2—urine—systemic lupus erythematosus	0.00105	0.0446	CbGeAlD
Naproxen—CYP2C9—urine—systemic lupus erythematosus	0.000992	0.0423	CbGeAlD
Naproxen—AKR1C3—nephron tubule—systemic lupus erythematosus	0.000689	0.0294	CbGeAlD
Naproxen—SLC22A6—nephron tubule—systemic lupus erythematosus	0.000686	0.0293	CbGeAlD
Naproxen—UGT2B7—kidney—systemic lupus erythematosus	0.000657	0.028	CbGeAlD
Naproxen—AKR1C3—cortex of kidney—systemic lupus erythematosus	0.00059	0.0252	CbGeAlD
Naproxen—SLC22A6—cortex of kidney—systemic lupus erythematosus	0.000587	0.0251	CbGeAlD
Naproxen—CYP2C8—blood plasma—systemic lupus erythematosus	0.000583	0.0249	CbGeAlD
Naproxen—UGT1A1—kidney—systemic lupus erythematosus	0.000558	0.0238	CbGeAlD
Naproxen—CYP1A2—blood plasma—systemic lupus erythematosus	0.000545	0.0233	CbGeAlD
Naproxen—PTGS1—endothelium—systemic lupus erythematosus	0.000532	0.0227	CbGeAlD
Naproxen—CYP2C9—blood plasma—systemic lupus erythematosus	0.000518	0.0221	CbGeAlD
Naproxen—PTGS2—endothelium—systemic lupus erythematosus	0.000509	0.0217	CbGeAlD
Naproxen—AKR1C3—tendon—systemic lupus erythematosus	0.000489	0.0209	CbGeAlD
Naproxen—AKR1C3—bone marrow—systemic lupus erythematosus	0.000474	0.0202	CbGeAlD
Naproxen—PTGS1—blood plasma—systemic lupus erythematosus	0.000473	0.0202	CbGeAlD
Naproxen—PTGS2—blood plasma—systemic lupus erythematosus	0.000452	0.0193	CbGeAlD
Naproxen—AKR1C3—lung—systemic lupus erythematosus	0.000429	0.0183	CbGeAlD
Naproxen—SLCO1A2—kidney—systemic lupus erythematosus	0.000378	0.0161	CbGeAlD
Naproxen—SLCO1A2—lung—systemic lupus erythematosus	0.000268	0.0114	CbGeAlD
Naproxen—CYP2C8—kidney—systemic lupus erythematosus	0.000264	0.0113	CbGeAlD
Naproxen—Nabumetone—PTGS2—systemic lupus erythematosus	0.000255	0.132	CrCbGaD
Naproxen—PTGS1—connective tissue—systemic lupus erythematosus	0.000252	0.0107	CbGeAlD
Naproxen—SLCO1A2—nervous system—systemic lupus erythematosus	0.000248	0.0106	CbGeAlD
Naproxen—PTGS2—Fluocinonide—Methylprednisolone—systemic lupus erythematosus	0.000245	0.159	CbGdCrCtD
Naproxen—Carprofen—PTGS2—systemic lupus erythematosus	0.000243	0.126	CrCbGaD
Naproxen—PTGS2—Fluocinonide—Betamethasone—systemic lupus erythematosus	0.000241	0.156	CbGdCrCtD
Naproxen—PTGS2—Fluocinonide—Dexamethasone—systemic lupus erythematosus	0.000241	0.156	CbGdCrCtD
Naproxen—PTGS2—connective tissue—systemic lupus erythematosus	0.000241	0.0103	CbGeAlD
Naproxen—SLCO1A2—central nervous system—systemic lupus erythematosus	0.000239	0.0102	CbGeAlD
Naproxen—PTGS2—Fluocinonide—Triamcinolone—systemic lupus erythematosus	0.000236	0.153	CbGdCrCtD
Naproxen—PTGS1—skin of body—systemic lupus erythematosus	0.000227	0.0097	CbGeAlD
Naproxen—Indomethacin—PPARG—systemic lupus erythematosus	0.000226	0.118	CrCbGaD
Naproxen—PTGS2—skin of body—systemic lupus erythematosus	0.000217	0.00927	CbGeAlD
Naproxen—PTGS1—kidney—systemic lupus erythematosus	0.000214	0.00914	CbGeAlD
Naproxen—PTGS2—kidney—systemic lupus erythematosus	0.000205	0.00874	CbGeAlD
Naproxen—Ibuprofen—PPARG—systemic lupus erythematosus	0.000178	0.0926	CrCbGaD
Naproxen—PTGS2—lymphoid tissue—systemic lupus erythematosus	0.000176	0.0075	CbGeAlD
Naproxen—CYP1A2—lung—systemic lupus erythematosus	0.000175	0.00747	CbGeAlD
Naproxen—PTGS1—tendon—systemic lupus erythematosus	0.000173	0.00738	CbGeAlD
Naproxen—PTGS2—tendon—systemic lupus erythematosus	0.000165	0.00705	CbGeAlD
Naproxen—PTGS2—bone marrow—systemic lupus erythematosus	0.00016	0.00683	CbGeAlD
Naproxen—PTGS1—lung—systemic lupus erythematosus	0.000152	0.00648	CbGeAlD
Naproxen—Suprofen—PTGS2—systemic lupus erythematosus	0.00015	0.0781	CrCbGaD
Naproxen—PTGS2—Fluticasone Propionate—Methylprednisolone—systemic lupus erythematosus	0.000148	0.0958	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Betamethasone—systemic lupus erythematosus	0.000145	0.0943	CbGdCrCtD
Naproxen—PTGS2—Fluticasone Propionate—Dexamethasone—systemic lupus erythematosus	0.000145	0.0943	CbGdCrCtD
Naproxen—PTGS2—lung—systemic lupus erythematosus	0.000145	0.00619	CbGeAlD
Naproxen—PTGS2—Fluticasone Propionate—Triamcinolone—systemic lupus erythematosus	0.000142	0.0921	CbGdCrCtD
Naproxen—PTGS1—nervous system—systemic lupus erythematosus	0.000141	0.006	CbGeAlD
Naproxen—PTGS1—central nervous system—systemic lupus erythematosus	0.000135	0.00577	CbGeAlD
Naproxen—PTGS2—nervous system—systemic lupus erythematosus	0.000134	0.00573	CbGeAlD
Naproxen—PTGS2—central nervous system—systemic lupus erythematosus	0.000129	0.00552	CbGeAlD
Naproxen—Fenoprofen—PTGS2—systemic lupus erythematosus	0.000129	0.0673	CrCbGaD
Naproxen—Fenoprofen—ALB—systemic lupus erythematosus	0.000115	0.0599	CrCbGaD
Naproxen—Indomethacin—PTGS2—systemic lupus erythematosus	9.54e-05	0.0496	CrCbGaD
Naproxen—Indomethacin—ALB—systemic lupus erythematosus	8.5e-05	0.0442	CrCbGaD
Naproxen—Flurbiprofen—PTGS2—systemic lupus erythematosus	8.44e-05	0.0439	CrCbGaD
Naproxen—Ketoprofen—PTGS2—systemic lupus erythematosus	7.63e-05	0.0397	CrCbGaD
Naproxen—Flurbiprofen—ALB—systemic lupus erythematosus	7.52e-05	0.0391	CrCbGaD
Naproxen—Ibuprofen—PTGS2—systemic lupus erythematosus	7.51e-05	0.0391	CrCbGaD
Naproxen—Ketoprofen—ALB—systemic lupus erythematosus	6.8e-05	0.0354	CrCbGaD
Naproxen—Ibuprofen—ALB—systemic lupus erythematosus	6.69e-05	0.0348	CrCbGaD
Naproxen—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	2.89e-05	0.000265	CcSEcCtD
Naproxen—Pain—Hydrocortisone—systemic lupus erythematosus	2.89e-05	0.000265	CcSEcCtD
Naproxen—Oedema—Betamethasone—systemic lupus erythematosus	2.88e-05	0.000265	CcSEcCtD
Naproxen—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	2.88e-05	0.000265	CcSEcCtD
Naproxen—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	2.88e-05	0.000265	CcSEcCtD
Naproxen—Oedema—Dexamethasone—systemic lupus erythematosus	2.88e-05	0.000265	CcSEcCtD
Naproxen—Insomnia—Triamcinolone—systemic lupus erythematosus	2.87e-05	0.000264	CcSEcCtD
Naproxen—Insomnia—Methylprednisolone—systemic lupus erythematosus	2.87e-05	0.000263	CcSEcCtD
Naproxen—Infection—Betamethasone—systemic lupus erythematosus	2.86e-05	0.000263	CcSEcCtD
Naproxen—Infection—Dexamethasone—systemic lupus erythematosus	2.86e-05	0.000263	CcSEcCtD
Naproxen—Ill-defined disorder—Prednisone—systemic lupus erythematosus	2.85e-05	0.000262	CcSEcCtD
Naproxen—Paraesthesia—Triamcinolone—systemic lupus erythematosus	2.85e-05	0.000262	CcSEcCtD
Naproxen—Feeling abnormal—Prednisolone—systemic lupus erythematosus	2.85e-05	0.000261	CcSEcCtD
Naproxen—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	2.85e-05	0.000261	CcSEcCtD
Naproxen—Visual impairment—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000261	CcSEcCtD
Naproxen—Anaemia—Prednisone—systemic lupus erythematosus	2.84e-05	0.000261	CcSEcCtD
Naproxen—Shock—Dexamethasone—systemic lupus erythematosus	2.84e-05	0.00026	CcSEcCtD
Naproxen—Shock—Betamethasone—systemic lupus erythematosus	2.84e-05	0.00026	CcSEcCtD
Naproxen—Dyspnoea—Triamcinolone—systemic lupus erythematosus	2.83e-05	0.00026	CcSEcCtD
Naproxen—Nervous system disorder—Betamethasone—systemic lupus erythematosus	2.83e-05	0.00026	CcSEcCtD
Naproxen—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	2.83e-05	0.00026	CcSEcCtD
Naproxen—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	2.82e-05	0.000259	CcSEcCtD
Naproxen—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	2.82e-05	0.000259	CcSEcCtD
Naproxen—Tachycardia—Betamethasone—systemic lupus erythematosus	2.81e-05	0.000258	CcSEcCtD
Naproxen—Tachycardia—Dexamethasone—systemic lupus erythematosus	2.81e-05	0.000258	CcSEcCtD
Naproxen—Angioedema—Prednisone—systemic lupus erythematosus	2.81e-05	0.000258	CcSEcCtD
Naproxen—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	2.8e-05	0.000257	CcSEcCtD
Naproxen—Dyspepsia—Triamcinolone—systemic lupus erythematosus	2.8e-05	0.000257	CcSEcCtD
Naproxen—Erythema multiforme—Methotrexate—systemic lupus erythematosus	2.79e-05	0.000256	CcSEcCtD
Naproxen—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	2.79e-05	0.000256	CcSEcCtD
Naproxen—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	2.79e-05	0.000256	CcSEcCtD
Naproxen—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	2.79e-05	0.000256	CcSEcCtD
Naproxen—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	2.78e-05	0.000255	CcSEcCtD
Naproxen—Malaise—Prednisone—systemic lupus erythematosus	2.77e-05	0.000255	CcSEcCtD
Naproxen—Vertigo—Prednisone—systemic lupus erythematosus	2.76e-05	0.000254	CcSEcCtD
Naproxen—Eye disorder—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000253	CcSEcCtD
Naproxen—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	2.76e-05	0.000253	CcSEcCtD
Naproxen—Syncope—Prednisone—systemic lupus erythematosus	2.76e-05	0.000253	CcSEcCtD
Naproxen—Tinnitus—Methotrexate—systemic lupus erythematosus	2.75e-05	0.000253	CcSEcCtD
Naproxen—Anorexia—Dexamethasone—systemic lupus erythematosus	2.75e-05	0.000252	CcSEcCtD
Naproxen—Anorexia—Betamethasone—systemic lupus erythematosus	2.75e-05	0.000252	CcSEcCtD
Naproxen—Urticaria—Prednisolone—systemic lupus erythematosus	2.75e-05	0.000252	CcSEcCtD
Naproxen—Cardiac disorder—Methotrexate—systemic lupus erythematosus	2.74e-05	0.000252	CcSEcCtD
Naproxen—Fatigue—Triamcinolone—systemic lupus erythematosus	2.74e-05	0.000251	CcSEcCtD
Naproxen—Fatigue—Methylprednisolone—systemic lupus erythematosus	2.73e-05	0.000251	CcSEcCtD
Naproxen—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	2.73e-05	0.00025	CcSEcCtD
Naproxen—Asthenia—Cyclosporine—systemic lupus erythematosus	2.72e-05	0.00025	CcSEcCtD
Naproxen—Pain—Triamcinolone—systemic lupus erythematosus	2.72e-05	0.000249	CcSEcCtD
Naproxen—Loss of consciousness—Prednisone—systemic lupus erythematosus	2.7e-05	0.000248	CcSEcCtD
Naproxen—Hypotension—Dexamethasone—systemic lupus erythematosus	2.69e-05	0.000247	CcSEcCtD
Naproxen—Hypotension—Betamethasone—systemic lupus erythematosus	2.69e-05	0.000247	CcSEcCtD
Naproxen—Pruritus—Cyclosporine—systemic lupus erythematosus	2.69e-05	0.000247	CcSEcCtD
Naproxen—Urticaria—Hydrocortisone—systemic lupus erythematosus	2.68e-05	0.000246	CcSEcCtD
Naproxen—Angiopathy—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000246	CcSEcCtD
Naproxen—Immune system disorder—Methotrexate—systemic lupus erythematosus	2.67e-05	0.000245	CcSEcCtD
Naproxen—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	2.67e-05	0.000245	CcSEcCtD
Naproxen—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	2.67e-05	0.000245	CcSEcCtD
Naproxen—Convulsion—Prednisone—systemic lupus erythematosus	2.67e-05	0.000245	CcSEcCtD
Naproxen—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	2.66e-05	0.000244	CcSEcCtD
Naproxen—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	2.66e-05	0.000244	CcSEcCtD
Naproxen—Hypertension—Prednisone—systemic lupus erythematosus	2.66e-05	0.000244	CcSEcCtD
Naproxen—Chills—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000243	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	2.63e-05	0.000241	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	2.63e-05	0.000241	CcSEcCtD
Naproxen—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	2.62e-05	0.000241	CcSEcCtD
Naproxen—Arthralgia—Prednisone—systemic lupus erythematosus	2.62e-05	0.00024	CcSEcCtD
Naproxen—Myalgia—Prednisone—systemic lupus erythematosus	2.62e-05	0.00024	CcSEcCtD
Naproxen—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	2.62e-05	0.00024	CcSEcCtD
Naproxen—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	2.61e-05	0.00024	CcSEcCtD
Naproxen—Anxiety—Prednisone—systemic lupus erythematosus	2.61e-05	0.00024	CcSEcCtD
Naproxen—Alopecia—Methotrexate—systemic lupus erythematosus	2.61e-05	0.00024	CcSEcCtD
Naproxen—Insomnia—Betamethasone—systemic lupus erythematosus	2.61e-05	0.000239	CcSEcCtD
Naproxen—Insomnia—Dexamethasone—systemic lupus erythematosus	2.61e-05	0.000239	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	2.6e-05	0.000239	CcSEcCtD
Naproxen—Diarrhoea—Cyclosporine—systemic lupus erythematosus	2.6e-05	0.000238	CcSEcCtD
Naproxen—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	2.59e-05	0.000238	CcSEcCtD
Naproxen—Paraesthesia—Dexamethasone—systemic lupus erythematosus	2.59e-05	0.000238	CcSEcCtD
Naproxen—Paraesthesia—Betamethasone—systemic lupus erythematosus	2.59e-05	0.000238	CcSEcCtD
Naproxen—Discomfort—Prednisone—systemic lupus erythematosus	2.59e-05	0.000238	CcSEcCtD
Naproxen—Mental disorder—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000237	CcSEcCtD
Naproxen—Malnutrition—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000236	CcSEcCtD
Naproxen—Erythema—Methotrexate—systemic lupus erythematosus	2.57e-05	0.000236	CcSEcCtD
Naproxen—Hypersensitivity—Prednisolone—systemic lupus erythematosus	2.55e-05	0.000234	CcSEcCtD
Naproxen—Dyspepsia—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000233	CcSEcCtD
Naproxen—Dyspepsia—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000233	CcSEcCtD
Naproxen—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	2.53e-05	0.000233	CcSEcCtD
Naproxen—Urticaria—Triamcinolone—systemic lupus erythematosus	2.52e-05	0.000232	CcSEcCtD
Naproxen—Urticaria—Methylprednisolone—systemic lupus erythematosus	2.52e-05	0.000231	CcSEcCtD
Naproxen—Body temperature increased—Triamcinolone—systemic lupus erythematosus	2.51e-05	0.000231	CcSEcCtD
Naproxen—Dizziness—Cyclosporine—systemic lupus erythematosus	2.51e-05	0.00023	CcSEcCtD
Naproxen—Oedema—Prednisone—systemic lupus erythematosus	2.51e-05	0.00023	CcSEcCtD
Naproxen—Anaphylactic shock—Prednisone—systemic lupus erythematosus	2.51e-05	0.00023	CcSEcCtD
Naproxen—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	2.51e-05	0.00023	CcSEcCtD
Naproxen—Decreased appetite—Betamethasone—systemic lupus erythematosus	2.51e-05	0.00023	CcSEcCtD
Naproxen—Decreased appetite—Dexamethasone—systemic lupus erythematosus	2.51e-05	0.00023	CcSEcCtD
Naproxen—Infection—Prednisone—systemic lupus erythematosus	2.49e-05	0.000229	CcSEcCtD
Naproxen—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	2.49e-05	0.000228	CcSEcCtD
Naproxen—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	2.49e-05	0.000228	CcSEcCtD
Naproxen—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	2.49e-05	0.000228	CcSEcCtD
Naproxen—Fatigue—Betamethasone—systemic lupus erythematosus	2.49e-05	0.000228	CcSEcCtD
Naproxen—Fatigue—Dexamethasone—systemic lupus erythematosus	2.49e-05	0.000228	CcSEcCtD
Naproxen—Shock—Prednisone—systemic lupus erythematosus	2.47e-05	0.000227	CcSEcCtD
Naproxen—Pain—Dexamethasone—systemic lupus erythematosus	2.47e-05	0.000226	CcSEcCtD
Naproxen—Pain—Betamethasone—systemic lupus erythematosus	2.47e-05	0.000226	CcSEcCtD
Naproxen—Nervous system disorder—Prednisone—systemic lupus erythematosus	2.46e-05	0.000226	CcSEcCtD
Naproxen—Tachycardia—Prednisone—systemic lupus erythematosus	2.45e-05	0.000225	CcSEcCtD
Naproxen—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	2.45e-05	0.000225	CcSEcCtD
Naproxen—Skin disorder—Prednisone—systemic lupus erythematosus	2.44e-05	0.000224	CcSEcCtD
Naproxen—Hyperhidrosis—Prednisone—systemic lupus erythematosus	2.43e-05	0.000223	CcSEcCtD
Naproxen—Vision blurred—Methotrexate—systemic lupus erythematosus	2.42e-05	0.000222	CcSEcCtD
Naproxen—Asthenia—Hydrocortisone—systemic lupus erythematosus	2.42e-05	0.000222	CcSEcCtD
Naproxen—Vomiting—Cyclosporine—systemic lupus erythematosus	2.41e-05	0.000222	CcSEcCtD
Naproxen—Rash—Cyclosporine—systemic lupus erythematosus	2.39e-05	0.00022	CcSEcCtD
Naproxen—Anorexia—Prednisone—systemic lupus erythematosus	2.39e-05	0.00022	CcSEcCtD
Naproxen—Dermatitis—Cyclosporine—systemic lupus erythematosus	2.39e-05	0.00022	CcSEcCtD
Naproxen—Pruritus—Hydrocortisone—systemic lupus erythematosus	2.39e-05	0.000219	CcSEcCtD
Naproxen—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	2.39e-05	0.000219	CcSEcCtD
Naproxen—Headache—Cyclosporine—systemic lupus erythematosus	2.38e-05	0.000218	CcSEcCtD
Naproxen—Anaemia—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000218	CcSEcCtD
Naproxen—Feeling abnormal—Betamethasone—systemic lupus erythematosus	2.38e-05	0.000218	CcSEcCtD
Naproxen—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	2.38e-05	0.000218	CcSEcCtD
Naproxen—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	2.36e-05	0.000216	CcSEcCtD
Naproxen—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	2.36e-05	0.000216	CcSEcCtD
Naproxen—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	2.36e-05	0.000216	CcSEcCtD
Naproxen—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	2.34e-05	0.000215	CcSEcCtD
Naproxen—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	2.34e-05	0.000214	CcSEcCtD
Naproxen—Rash—Mycophenolate mofetil—systemic lupus erythematosus	2.34e-05	0.000214	CcSEcCtD
Naproxen—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	2.33e-05	0.000214	CcSEcCtD
Naproxen—Headache—Mycophenolate mofetil—systemic lupus erythematosus	2.32e-05	0.000213	CcSEcCtD
Naproxen—Malaise—Methotrexate—systemic lupus erythematosus	2.32e-05	0.000213	CcSEcCtD
Naproxen—Vertigo—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000212	CcSEcCtD
Naproxen—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	2.31e-05	0.000212	CcSEcCtD
Naproxen—Leukopenia—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000211	CcSEcCtD
Naproxen—Urticaria—Betamethasone—systemic lupus erythematosus	2.29e-05	0.00021	CcSEcCtD
Naproxen—Urticaria—Dexamethasone—systemic lupus erythematosus	2.29e-05	0.00021	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	2.29e-05	0.00021	CcSEcCtD
Naproxen—Dizziness—Prednisolone—systemic lupus erythematosus	2.29e-05	0.00021	CcSEcCtD
Naproxen—Asthenia—Triamcinolone—systemic lupus erythematosus	2.28e-05	0.000209	CcSEcCtD
Naproxen—Abdominal pain—Dexamethasone—systemic lupus erythematosus	2.28e-05	0.000209	CcSEcCtD
Naproxen—Body temperature increased—Betamethasone—systemic lupus erythematosus	2.28e-05	0.000209	CcSEcCtD
Naproxen—Body temperature increased—Dexamethasone—systemic lupus erythematosus	2.28e-05	0.000209	CcSEcCtD
Naproxen—Abdominal pain—Betamethasone—systemic lupus erythematosus	2.28e-05	0.000209	CcSEcCtD
Naproxen—Asthenia—Methylprednisolone—systemic lupus erythematosus	2.28e-05	0.000209	CcSEcCtD
Naproxen—Insomnia—Prednisone—systemic lupus erythematosus	2.27e-05	0.000208	CcSEcCtD
Naproxen—Nausea—Cyclosporine—systemic lupus erythematosus	2.26e-05	0.000207	CcSEcCtD
Naproxen—Paraesthesia—Prednisone—systemic lupus erythematosus	2.25e-05	0.000207	CcSEcCtD
Naproxen—Pruritus—Triamcinolone—systemic lupus erythematosus	2.25e-05	0.000206	CcSEcCtD
Naproxen—Cough—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000206	CcSEcCtD
Naproxen—Pruritus—Methylprednisolone—systemic lupus erythematosus	2.24e-05	0.000206	CcSEcCtD
Naproxen—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.23e-05	0.000205	CcSEcCtD
Naproxen—Convulsion—Methotrexate—systemic lupus erythematosus	2.23e-05	0.000204	CcSEcCtD
Naproxen—Dyspepsia—Prednisone—systemic lupus erythematosus	2.21e-05	0.000203	CcSEcCtD
Naproxen—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.2e-05	0.000202	CcSEcCtD
Naproxen—Chest pain—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000201	CcSEcCtD
Naproxen—Myalgia—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000201	CcSEcCtD
Naproxen—Arthralgia—Methotrexate—systemic lupus erythematosus	2.19e-05	0.000201	CcSEcCtD
Naproxen—Decreased appetite—Prednisone—systemic lupus erythematosus	2.18e-05	0.0002	CcSEcCtD
Naproxen—Rash—Prednisolone—systemic lupus erythematosus	2.18e-05	0.0002	CcSEcCtD
Naproxen—Dermatitis—Prednisolone—systemic lupus erythematosus	2.18e-05	0.0002	CcSEcCtD
Naproxen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.17e-05	0.0002	CcSEcCtD
Naproxen—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.17e-05	0.000199	CcSEcCtD
Naproxen—Fatigue—Prednisone—systemic lupus erythematosus	2.17e-05	0.000199	CcSEcCtD
Naproxen—Headache—Prednisolone—systemic lupus erythematosus	2.16e-05	0.000199	CcSEcCtD
Naproxen—Discomfort—Methotrexate—systemic lupus erythematosus	2.16e-05	0.000198	CcSEcCtD
Naproxen—Constipation—Prednisone—systemic lupus erythematosus	2.15e-05	0.000197	CcSEcCtD
Naproxen—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.15e-05	0.000197	CcSEcCtD
Naproxen—Rash—Hydrocortisone—systemic lupus erythematosus	2.13e-05	0.000195	CcSEcCtD
Naproxen—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.13e-05	0.000195	CcSEcCtD
Naproxen—Confusional state—Methotrexate—systemic lupus erythematosus	2.12e-05	0.000194	CcSEcCtD
Naproxen—Headache—Hydrocortisone—systemic lupus erythematosus	2.11e-05	0.000194	CcSEcCtD
Naproxen—Dizziness—Triamcinolone—systemic lupus erythematosus	2.1e-05	0.000193	CcSEcCtD
Naproxen—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.1e-05	0.000193	CcSEcCtD
Naproxen—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.1e-05	0.000192	CcSEcCtD
Naproxen—Infection—Methotrexate—systemic lupus erythematosus	2.09e-05	0.000191	CcSEcCtD
Naproxen—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.07e-05	0.00019	CcSEcCtD
Naproxen—Asthenia—Dexamethasone—systemic lupus erythematosus	2.07e-05	0.00019	CcSEcCtD
Naproxen—Asthenia—Betamethasone—systemic lupus erythematosus	2.07e-05	0.00019	CcSEcCtD
Naproxen—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000189	CcSEcCtD
Naproxen—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.05e-05	0.000189	CcSEcCtD
Naproxen—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.05e-05	0.000188	CcSEcCtD
Naproxen—Nausea—Prednisolone—systemic lupus erythematosus	2.05e-05	0.000188	CcSEcCtD
Naproxen—Pruritus—Dexamethasone—systemic lupus erythematosus	2.04e-05	0.000187	CcSEcCtD
Naproxen—Pruritus—Betamethasone—systemic lupus erythematosus	2.04e-05	0.000187	CcSEcCtD
Naproxen—Skin disorder—Methotrexate—systemic lupus erythematosus	2.04e-05	0.000187	CcSEcCtD
Naproxen—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.03e-05	0.000186	CcSEcCtD
Naproxen—Vomiting—Triamcinolone—systemic lupus erythematosus	2.02e-05	0.000185	CcSEcCtD
Naproxen—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.02e-05	0.000185	CcSEcCtD
Naproxen—Nausea—Hydrocortisone—systemic lupus erythematosus	2e-05	0.000184	CcSEcCtD
Naproxen—Rash—Triamcinolone—systemic lupus erythematosus	2e-05	0.000184	CcSEcCtD
Naproxen—Dermatitis—Triamcinolone—systemic lupus erythematosus	2e-05	0.000184	CcSEcCtD
Naproxen—Anorexia—Methotrexate—systemic lupus erythematosus	2e-05	0.000184	CcSEcCtD
Naproxen—Rash—Methylprednisolone—systemic lupus erythematosus	2e-05	0.000183	CcSEcCtD
Naproxen—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2e-05	0.000183	CcSEcCtD
Naproxen—Urticaria—Prednisone—systemic lupus erythematosus	1.99e-05	0.000183	CcSEcCtD
Naproxen—Headache—Triamcinolone—systemic lupus erythematosus	1.99e-05	0.000183	CcSEcCtD
Naproxen—Headache—Methylprednisolone—systemic lupus erythematosus	1.99e-05	0.000182	CcSEcCtD
Naproxen—Body temperature increased—Prednisone—systemic lupus erythematosus	1.99e-05	0.000182	CcSEcCtD
Naproxen—Abdominal pain—Prednisone—systemic lupus erythematosus	1.99e-05	0.000182	CcSEcCtD
Naproxen—Diarrhoea—Betamethasone—systemic lupus erythematosus	1.97e-05	0.000181	CcSEcCtD
Naproxen—Diarrhoea—Dexamethasone—systemic lupus erythematosus	1.97e-05	0.000181	CcSEcCtD
Naproxen—Hypotension—Methotrexate—systemic lupus erythematosus	1.96e-05	0.00018	CcSEcCtD
Naproxen—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	1.91e-05	0.000175	CcSEcCtD
Naproxen—Dizziness—Dexamethasone—systemic lupus erythematosus	1.91e-05	0.000175	CcSEcCtD
Naproxen—Dizziness—Betamethasone—systemic lupus erythematosus	1.91e-05	0.000175	CcSEcCtD
Naproxen—Insomnia—Methotrexate—systemic lupus erythematosus	1.9e-05	0.000174	CcSEcCtD
Naproxen—Nausea—Triamcinolone—systemic lupus erythematosus	1.89e-05	0.000173	CcSEcCtD
Naproxen—Paraesthesia—Methotrexate—systemic lupus erythematosus	1.88e-05	0.000173	CcSEcCtD
Naproxen—Nausea—Methylprednisolone—systemic lupus erythematosus	1.88e-05	0.000173	CcSEcCtD
Naproxen—Dyspnoea—Methotrexate—systemic lupus erythematosus	1.87e-05	0.000172	CcSEcCtD
Naproxen—Somnolence—Methotrexate—systemic lupus erythematosus	1.87e-05	0.000171	CcSEcCtD
Naproxen—Hypersensitivity—Prednisone—systemic lupus erythematosus	1.85e-05	0.00017	CcSEcCtD
Naproxen—Dyspepsia—Methotrexate—systemic lupus erythematosus	1.85e-05	0.00017	CcSEcCtD
Naproxen—Vomiting—Betamethasone—systemic lupus erythematosus	1.83e-05	0.000168	CcSEcCtD
Naproxen—Vomiting—Dexamethasone—systemic lupus erythematosus	1.83e-05	0.000168	CcSEcCtD
Naproxen—Decreased appetite—Methotrexate—systemic lupus erythematosus	1.82e-05	0.000167	CcSEcCtD
Naproxen—Rash—Betamethasone—systemic lupus erythematosus	1.82e-05	0.000167	CcSEcCtD
Naproxen—Rash—Dexamethasone—systemic lupus erythematosus	1.82e-05	0.000167	CcSEcCtD
Naproxen—Dermatitis—Dexamethasone—systemic lupus erythematosus	1.82e-05	0.000167	CcSEcCtD
Naproxen—Dermatitis—Betamethasone—systemic lupus erythematosus	1.82e-05	0.000167	CcSEcCtD
Naproxen—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	1.81e-05	0.000166	CcSEcCtD
Naproxen—Fatigue—Methotrexate—systemic lupus erythematosus	1.81e-05	0.000166	CcSEcCtD
Naproxen—Headache—Dexamethasone—systemic lupus erythematosus	1.81e-05	0.000166	CcSEcCtD
Naproxen—Headache—Betamethasone—systemic lupus erythematosus	1.81e-05	0.000166	CcSEcCtD
Naproxen—Asthenia—Prednisone—systemic lupus erythematosus	1.8e-05	0.000165	CcSEcCtD
Naproxen—Pain—Methotrexate—systemic lupus erythematosus	1.79e-05	0.000165	CcSEcCtD
Naproxen—Pruritus—Prednisone—systemic lupus erythematosus	1.78e-05	0.000163	CcSEcCtD
Naproxen—Feeling abnormal—Methotrexate—systemic lupus erythematosus	1.73e-05	0.000159	CcSEcCtD
Naproxen—Diarrhoea—Prednisone—systemic lupus erythematosus	1.72e-05	0.000158	CcSEcCtD
Naproxen—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	1.72e-05	0.000157	CcSEcCtD
Naproxen—Nausea—Dexamethasone—systemic lupus erythematosus	1.71e-05	0.000157	CcSEcCtD
Naproxen—Nausea—Betamethasone—systemic lupus erythematosus	1.71e-05	0.000157	CcSEcCtD
Naproxen—Urticaria—Methotrexate—systemic lupus erythematosus	1.67e-05	0.000153	CcSEcCtD
Naproxen—Dizziness—Prednisone—systemic lupus erythematosus	1.66e-05	0.000152	CcSEcCtD
Naproxen—Abdominal pain—Methotrexate—systemic lupus erythematosus	1.66e-05	0.000152	CcSEcCtD
Naproxen—Body temperature increased—Methotrexate—systemic lupus erythematosus	1.66e-05	0.000152	CcSEcCtD
Naproxen—Vomiting—Prednisone—systemic lupus erythematosus	1.6e-05	0.000147	CcSEcCtD
Naproxen—Rash—Prednisone—systemic lupus erythematosus	1.58e-05	0.000145	CcSEcCtD
Naproxen—Dermatitis—Prednisone—systemic lupus erythematosus	1.58e-05	0.000145	CcSEcCtD
Naproxen—Headache—Prednisone—systemic lupus erythematosus	1.57e-05	0.000144	CcSEcCtD
Naproxen—Hypersensitivity—Methotrexate—systemic lupus erythematosus	1.55e-05	0.000142	CcSEcCtD
Naproxen—Asthenia—Methotrexate—systemic lupus erythematosus	1.51e-05	0.000138	CcSEcCtD
Naproxen—Nausea—Prednisone—systemic lupus erythematosus	1.49e-05	0.000137	CcSEcCtD
Naproxen—Pruritus—Methotrexate—systemic lupus erythematosus	1.48e-05	0.000136	CcSEcCtD
Naproxen—PTGS2—C-MYB transcription factor network—CDKN1B—systemic lupus erythematosus	1.48e-05	0.00147	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CCL2—systemic lupus erythematosus	1.46e-05	0.00145	CbGpPWpGaD
Naproxen—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	1.44e-05	0.00144	CbGpPWpGaD
Naproxen—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.44e-05	0.000132	CcSEcCtD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	1.43e-05	0.00143	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL2—systemic lupus erythematosus	1.42e-05	0.00141	CbGpPWpGaD
Naproxen—Dizziness—Methotrexate—systemic lupus erythematosus	1.39e-05	0.000127	CcSEcCtD
Naproxen—UGT2B7—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.38e-05	0.00137	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—CDKN1A—systemic lupus erythematosus	1.36e-05	0.00136	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	1.35e-05	0.00135	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	1.35e-05	0.00135	CbGpPWpGaD
Naproxen—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	1.34e-05	0.00133	CbGpPWpGaD
Naproxen—Vomiting—Methotrexate—systemic lupus erythematosus	1.33e-05	0.000122	CcSEcCtD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	1.33e-05	0.00133	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	1.32e-05	0.00132	CbGpPWpGaD
Naproxen—Rash—Methotrexate—systemic lupus erythematosus	1.32e-05	0.000121	CcSEcCtD
Naproxen—Dermatitis—Methotrexate—systemic lupus erythematosus	1.32e-05	0.000121	CcSEcCtD
Naproxen—Headache—Methotrexate—systemic lupus erythematosus	1.31e-05	0.000121	CcSEcCtD
Naproxen—AKR1C3—Signaling Pathways—TLR9—systemic lupus erythematosus	1.31e-05	0.0013	CbGpPWpGaD
Naproxen—PTGS2—C-MYB transcription factor network—EP300—systemic lupus erythematosus	1.3e-05	0.00129	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	1.29e-05	0.00128	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.28e-05	0.00127	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—RASGRP1—systemic lupus erythematosus	1.27e-05	0.00127	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—TNF—systemic lupus erythematosus	1.27e-05	0.00127	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	1.27e-05	0.00126	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—P2RY12—systemic lupus erythematosus	1.27e-05	0.00126	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	1.25e-05	0.00125	CbGpPWpGaD
Naproxen—Nausea—Methotrexate—systemic lupus erythematosus	1.25e-05	0.000114	CcSEcCtD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.24e-05	0.00124	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IFNG—systemic lupus erythematosus	1.24e-05	0.00124	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	1.22e-05	0.00121	CbGpPWpGaD
Naproxen—ALB—Hemostasis—ITGAX—systemic lupus erythematosus	1.21e-05	0.00121	CbGpPWpGaD
Naproxen—SLCO1A2—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.2e-05	0.00119	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	1.19e-05	0.00119	CbGpPWpGaD
Naproxen—AKR1C3—Disease—JUNB—systemic lupus erythematosus	1.19e-05	0.00119	CbGpPWpGaD
Naproxen—ALB—Hemostasis—F3—systemic lupus erythematosus	1.19e-05	0.00119	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	1.19e-05	0.00119	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	1.19e-05	0.00119	CbGpPWpGaD
Naproxen—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	1.17e-05	0.00117	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CSK—systemic lupus erythematosus	1.16e-05	0.00116	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	1.13e-05	0.00112	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	1.13e-05	0.00112	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.13e-05	0.00112	CbGpPWpGaD
Naproxen—SLC22A6—SLC-mediated transmembrane transport—ALB—systemic lupus erythematosus	1.12e-05	0.00112	CbGpPWpGaD
Naproxen—UGT1A1—NRF2 pathway—TGFB1—systemic lupus erythematosus	1.12e-05	0.00112	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.12e-05	0.00111	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL2—systemic lupus erythematosus	1.1e-05	0.0011	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PRL—systemic lupus erythematosus	1.1e-05	0.0011	CbGpPWpGaD
Naproxen—ALB—Hemostasis—CLU—systemic lupus erythematosus	1.08e-05	0.00107	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.07e-05	0.00107	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NCF2—systemic lupus erythematosus	1.06e-05	0.00106	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—LYN—systemic lupus erythematosus	1.06e-05	0.00106	CbGpPWpGaD
Naproxen—ALB—Hemostasis—P2RY12—systemic lupus erythematosus	1.04e-05	0.00104	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—MMP9—systemic lupus erythematosus	1.04e-05	0.00104	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—SH2B3—systemic lupus erythematosus	1.04e-05	0.00104	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—VEGFA—systemic lupus erythematosus	1.03e-05	0.00103	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—TNF—systemic lupus erythematosus	1.03e-05	0.00103	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	1.03e-05	0.00103	CbGpPWpGaD
Naproxen—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	1.03e-05	0.00103	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NAT2—systemic lupus erythematosus	1.03e-05	0.00102	CbGpPWpGaD
Naproxen—ALB—Vitamin B12 Metabolism—IL6—systemic lupus erythematosus	1.02e-05	0.00102	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	1.01e-05	0.00101	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	1.01e-05	0.001	CbGpPWpGaD
Naproxen—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	1e-05	0.000999	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—JAK1—systemic lupus erythematosus	9.85e-06	0.000983	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—systemic lupus erythematosus	9.84e-06	0.000982	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	9.77e-06	0.000975	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	9.65e-06	0.000962	CbGpPWpGaD
Naproxen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	9.65e-06	0.000962	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SELE—systemic lupus erythematosus	9.6e-06	0.000958	CbGpPWpGaD
Naproxen—ALB—Hemostasis—CSK—systemic lupus erythematosus	9.6e-06	0.000958	CbGpPWpGaD
Naproxen—ALB—Platelet degranulation—TGFB1—systemic lupus erythematosus	9.49e-06	0.000946	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2RA—systemic lupus erythematosus	9.2e-06	0.000918	CbGpPWpGaD
Naproxen—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—systemic lupus erythematosus	9.04e-06	0.000901	CbGpPWpGaD
Naproxen—ALB—Hemostasis—ITGAM—systemic lupus erythematosus	9.03e-06	0.000901	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NAT2—systemic lupus erythematosus	8.94e-06	0.000892	CbGpPWpGaD
Naproxen—AKR1C3—Disease—JAK1—systemic lupus erythematosus	8.79e-06	0.000877	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—RXRA—systemic lupus erythematosus	8.76e-06	0.000874	CbGpPWpGaD
Naproxen—ALB—Hemostasis—LYN—systemic lupus erythematosus	8.72e-06	0.00087	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	8.59e-06	0.000857	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	8.56e-06	0.000854	CbGpPWpGaD
Naproxen—ALB—Hemostasis—SH2B3—systemic lupus erythematosus	8.56e-06	0.000854	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CXCL12—systemic lupus erythematosus	8.51e-06	0.000849	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—JUNB—systemic lupus erythematosus	8.36e-06	0.000834	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NAT2—systemic lupus erythematosus	8.34e-06	0.000832	CbGpPWpGaD
Naproxen—ALB—Folate Metabolism—IL6—systemic lupus erythematosus	8.34e-06	0.000832	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CCR5—systemic lupus erythematosus	8.33e-06	0.000831	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	8.21e-06	0.000819	CbGpPWpGaD
Naproxen—PTGS2—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	8.19e-06	0.000817	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.12e-06	0.000811	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—TNF—systemic lupus erythematosus	8.02e-06	0.0008	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—F2—systemic lupus erythematosus	8.01e-06	0.000799	CbGpPWpGaD
Naproxen—PTGS2—Disease—XRCC6—systemic lupus erythematosus	8e-06	0.000798	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—RASGRP1—systemic lupus erythematosus	7.94e-06	0.000792	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—PRL—systemic lupus erythematosus	7.7e-06	0.000768	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	7.66e-06	0.000764	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	7.1e-06	0.000709	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	7.07e-06	0.000705	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD80—systemic lupus erythematosus	6.85e-06	0.000684	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	6.8e-06	0.000678	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.8e-06	0.000678	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IFNA1—systemic lupus erythematosus	6.72e-06	0.000671	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	6.72e-06	0.000671	CbGpPWpGaD
Naproxen—ALB—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	6.62e-06	0.000661	CbGpPWpGaD
Naproxen—ALB—Hemostasis—RASGRP1—systemic lupus erythematosus	6.55e-06	0.000653	CbGpPWpGaD
Naproxen—PTGS2—Spinal Cord Injury—IL6—systemic lupus erythematosus	6.47e-06	0.000646	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	6.39e-06	0.000637	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	6.37e-06	0.000635	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—JAK1—systemic lupus erythematosus	6.16e-06	0.000614	CbGpPWpGaD
Naproxen—SLCO1A2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	6.07e-06	0.000606	CbGpPWpGaD
Naproxen—PTGS2—Disease—HIST2H2AC—systemic lupus erythematosus	5.9e-06	0.000588	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	5.84e-06	0.000583	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCR5—systemic lupus erythematosus	5.84e-06	0.000582	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TYK2—systemic lupus erythematosus	5.79e-06	0.000577	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—RXRA—systemic lupus erythematosus	5.76e-06	0.000574	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2RA—systemic lupus erythematosus	5.75e-06	0.000574	CbGpPWpGaD
Naproxen—PTGS2—Disease—CSK—systemic lupus erythematosus	5.75e-06	0.000573	CbGpPWpGaD
Naproxen—SLC22A6—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	5.71e-06	0.00057	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—C3—systemic lupus erythematosus	5.7e-06	0.000569	CbGpPWpGaD
Naproxen—AKR1C3—Disease—NOS3—systemic lupus erythematosus	5.68e-06	0.000567	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	5.59e-06	0.000558	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PPARG—systemic lupus erythematosus	5.53e-06	0.000552	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.53e-06	0.000552	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	5.5e-06	0.000549	CbGpPWpGaD
Naproxen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	5.46e-06	0.000544	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.41e-06	0.000539	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD247—systemic lupus erythematosus	5.4e-06	0.000539	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NAT2—systemic lupus erythematosus	5.4e-06	0.000539	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—IL2—systemic lupus erythematosus	5.39e-06	0.000538	CbGpPWpGaD
Naproxen—PTGS2—Disease—NCF2—systemic lupus erythematosus	5.26e-06	0.000524	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CD4—systemic lupus erythematosus	5.23e-06	0.000522	CbGpPWpGaD
Naproxen—ALB—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.23e-06	0.000522	CbGpPWpGaD
Naproxen—AKR1C3—Disease—PTGS2—systemic lupus erythematosus	5.19e-06	0.000518	CbGpPWpGaD
Naproxen—ALB—Hemostasis—JAK1—systemic lupus erythematosus	5.08e-06	0.000507	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—RXRA—systemic lupus erythematosus	5.01e-06	0.0005	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—F2—systemic lupus erythematosus	5.01e-06	0.000499	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—ALB—systemic lupus erythematosus	4.97e-06	0.000496	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CDKN1B—systemic lupus erythematosus	4.92e-06	0.000491	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.86e-06	0.000485	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CD80—systemic lupus erythematosus	4.8e-06	0.000479	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—NOS3—systemic lupus erythematosus	4.76e-06	0.000475	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2RA—systemic lupus erythematosus	4.74e-06	0.000473	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—RXRA—systemic lupus erythematosus	4.68e-06	0.000467	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	4.65e-06	0.000464	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—VEGFA—systemic lupus erythematosus	4.58e-06	0.000457	CbGpPWpGaD
Naproxen—AKR1C3—Disease—CDKN1A—systemic lupus erythematosus	4.54e-06	0.000453	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.5e-06	0.000449	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CCL2—systemic lupus erythematosus	4.46e-06	0.000445	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	4.39e-06	0.000438	CbGpPWpGaD
Naproxen—ALB—Metabolism—NAT2—systemic lupus erythematosus	4.37e-06	0.000436	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—PTGS2—systemic lupus erythematosus	4.35e-06	0.000434	CbGpPWpGaD
Naproxen—AKR1C3—Disease—EP300—systemic lupus erythematosus	4.32e-06	0.000431	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.29e-06	0.000428	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.25e-06	0.000424	CbGpPWpGaD
Naproxen—ALB—Platelet activation, signaling and aggregation—TGFB1—systemic lupus erythematosus	4.21e-06	0.00042	CbGpPWpGaD
Naproxen—ALB—Hemostasis—F2—systemic lupus erythematosus	4.13e-06	0.000412	CbGpPWpGaD
Naproxen—PTGS2—Disease—JUNB—systemic lupus erythematosus	4.12e-06	0.000411	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TYK2—systemic lupus erythematosus	4.05e-06	0.000404	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—NOS3—systemic lupus erythematosus	3.98e-06	0.000397	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.86e-06	0.000385	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.85e-06	0.000384	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	3.81e-06	0.00038	CbGpPWpGaD
Naproxen—PTGS2—Disease—PRL—systemic lupus erythematosus	3.8e-06	0.000379	CbGpPWpGaD
Naproxen—AKR1C3—Disease—TGFB1—systemic lupus erythematosus	3.76e-06	0.000375	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PPARG—systemic lupus erythematosus	3.63e-06	0.000363	CbGpPWpGaD
Naproxen—AKR1C3—Metabolism—EP300—systemic lupus erythematosus	3.62e-06	0.000361	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	3.58e-06	0.000357	CbGpPWpGaD
Naproxen—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.54e-06	0.000353	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.49e-06	0.000348	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.47e-06	0.000346	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.45e-06	0.000344	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL2—systemic lupus erythematosus	3.37e-06	0.000336	CbGpPWpGaD
Naproxen—ALB—Hemostasis—NOS3—systemic lupus erythematosus	3.28e-06	0.000327	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—ALB—systemic lupus erythematosus	3.27e-06	0.000326	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.19e-06	0.000318	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.18e-06	0.000317	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PPARG—systemic lupus erythematosus	3.16e-06	0.000316	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.14e-06	0.000313	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—NOS3—systemic lupus erythematosus	3.13e-06	0.000312	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	3.06e-06	0.000305	CbGpPWpGaD
Naproxen—PTGS2—Disease—JAK1—systemic lupus erythematosus	3.04e-06	0.000303	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—RXRA—systemic lupus erythematosus	3.03e-06	0.000302	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—EP300—systemic lupus erythematosus	3.03e-06	0.000302	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PPARG—systemic lupus erythematosus	2.95e-06	0.000295	CbGpPWpGaD
Naproxen—PTGS2—Disease—CCR5—systemic lupus erythematosus	2.88e-06	0.000287	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.87e-06	0.000286	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—PTGS2—systemic lupus erythematosus	2.86e-06	0.000285	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—ALB—systemic lupus erythematosus	2.85e-06	0.000284	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.84e-06	0.000283	CbGpPWpGaD
Naproxen—AKR1C3—Disease—IL6—systemic lupus erythematosus	2.83e-06	0.000282	CbGpPWpGaD
Naproxen—PTGS2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.81e-06	0.00028	CbGpPWpGaD
Naproxen—ALB—Hemostasis—IL2—systemic lupus erythematosus	2.78e-06	0.000277	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.75e-06	0.000274	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.73e-06	0.000272	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—NOS3—systemic lupus erythematosus	2.72e-06	0.000272	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—ALB—systemic lupus erythematosus	2.66e-06	0.000265	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.63e-06	0.000262	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.55e-06	0.000255	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—NOS3—systemic lupus erythematosus	2.54e-06	0.000253	CbGpPWpGaD
Naproxen—ALB—Hemostasis—EP300—systemic lupus erythematosus	2.49e-06	0.000249	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.49e-06	0.000248	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	2.46e-06	0.000246	CbGpPWpGaD
Naproxen—ALB—Metabolism—RXRA—systemic lupus erythematosus	2.45e-06	0.000244	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.43e-06	0.000242	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	2.41e-06	0.00024	CbGpPWpGaD
Naproxen—UGT2B7—Metabolism—EP300—systemic lupus erythematosus	2.38e-06	0.000237	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD80—systemic lupus erythematosus	2.37e-06	0.000236	CbGpPWpGaD
Naproxen—ALB—Hemostasis—VEGFA—systemic lupus erythematosus	2.36e-06	0.000236	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—PTGS2—systemic lupus erythematosus	2.32e-06	0.000232	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.28e-06	0.000228	CbGpPWpGaD
Naproxen—ALB—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.27e-06	0.000227	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.24e-06	0.000223	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.18e-06	0.000218	CbGpPWpGaD
Naproxen—ALB—Hemostasis—TGFB1—systemic lupus erythematosus	2.17e-06	0.000216	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—ALB—systemic lupus erythematosus	2.16e-06	0.000216	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	2.07e-06	0.000207	CbGpPWpGaD
Naproxen—SLCO1A2—Metabolism—EP300—systemic lupus erythematosus	2.07e-06	0.000207	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	2e-06	0.0002	CbGpPWpGaD
Naproxen—PTGS2—Disease—TYK2—systemic lupus erythematosus	2e-06	0.000199	CbGpPWpGaD
Naproxen—AKR1C3—Signaling Pathways—IL6—systemic lupus erythematosus	1.98e-06	0.000198	CbGpPWpGaD
Naproxen—PTGS2—Disease—NOS3—systemic lupus erythematosus	1.96e-06	0.000196	CbGpPWpGaD
Naproxen—UGT1A1—Metabolism—EP300—systemic lupus erythematosus	1.93e-06	0.000193	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—PPARG—systemic lupus erythematosus	1.91e-06	0.000191	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.91e-06	0.000191	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	1.89e-06	0.000189	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.86e-06	0.000185	CbGpPWpGaD
Naproxen—PTGS2—Disease—CD4—systemic lupus erythematosus	1.81e-06	0.00018	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—ALB—systemic lupus erythematosus	1.72e-06	0.000171	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	1.71e-06	0.000171	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN1B—systemic lupus erythematosus	1.7e-06	0.00017	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—NOS3—systemic lupus erythematosus	1.64e-06	0.000164	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.59e-06	0.000158	CbGpPWpGaD
Naproxen—PTGS1—Metabolism—EP300—systemic lupus erythematosus	1.57e-06	0.000157	CbGpPWpGaD
Naproxen—PTGS2—Disease—CDKN1A—systemic lupus erythematosus	1.57e-06	0.000157	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	1.55e-06	0.000155	CbGpPWpGaD
Naproxen—ALB—Metabolism—PPARG—systemic lupus erythematosus	1.55e-06	0.000154	CbGpPWpGaD
Naproxen—PTGS2—Disease—EP300—systemic lupus erythematosus	1.49e-06	0.000149	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	1.4e-06	0.000139	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	1.34e-06	0.000133	CbGpPWpGaD
Naproxen—ALB—Metabolism—NOS3—systemic lupus erythematosus	1.33e-06	0.000133	CbGpPWpGaD
Naproxen—PTGS2—Disease—TGFB1—systemic lupus erythematosus	1.3e-06	0.000129	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	1.27e-06	0.000126	CbGpPWpGaD
Naproxen—PTGS2—Metabolism—EP300—systemic lupus erythematosus	1.25e-06	0.000125	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	1.22e-06	0.000122	CbGpPWpGaD
Naproxen—ALB—Metabolism—PTGS2—systemic lupus erythematosus	1.22e-06	0.000121	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	1.14e-06	0.000114	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	1.09e-06	0.000109	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	1.08e-06	0.000108	CbGpPWpGaD
Naproxen—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	1.02e-06	0.000101	CbGpPWpGaD
Naproxen—ALB—Metabolism—EP300—systemic lupus erythematosus	1.01e-06	0.000101	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	9.95e-07	9.93e-05	CbGpPWpGaD
Naproxen—PTGS2—Disease—IL6—systemic lupus erythematosus	9.78e-07	9.76e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	9.72e-07	9.7e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	9.3e-07	9.28e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	8.51e-07	8.49e-05	CbGpPWpGaD
Naproxen—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	8.28e-07	8.26e-05	CbGpPWpGaD
Naproxen—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	7.07e-07	7.06e-05	CbGpPWpGaD
